Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: AMLX) | Delayed: 28.01 -0.56 (1.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.57 | 52 Week High | $ | |||
| Open | $28.33 | 52 Week Low | $ | |||
| Day High | $28.46 | P/E | N/A | |||
| Day Low | $27.70 | EPS | $ | |||
| Volume | 14,336 | |||||
